Huntington’s disease in the AI era evaluates cure claims and regulatory reality in 2025
Huntington’s disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or halt neurodegeneration. The evidence base points in one direction. Approved drugs manage manifestations such as chorea and psychiatric symptoms. Investigational therapies that target the mutant huntingtin pathway aim for disease […]